Novavax's quarterly additional paid-in capital
increased
from Mar. 2020 ($1,450.3 Mil) to Jun. 2020 ($1,699.1 Mil) and
increased
from Jun. 2020 ($1,699.1 Mil) to Sep. 2020 ($1,848.6 Mil).
Novavax's annual additional paid-in capital
increased
from Dec. 2017 ($1,020.5 Mil) to Dec. 2018 ($1,144.6 Mil) and
increased
from Dec. 2018 ($1,144.6 Mil) to Dec. 2019 ($1,260.6 Mil).
Novavax Additional Paid-In Capital Calculation
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
Novavax Additional Paid-In Capital Headlines
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
34.3(14.27%) Volume: 6,252,446 9:09PM EST
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP
NAS:NVAX has been successfully added to your 
